CDS-PD:一个新的临床决策支持平台,用于帕金森病
medRxiv : the preprint server for health sciences
|August 8, 2025
概括
一个新的临床决策支持平台 (CDS-PD) 有助于应用运动障碍学会对帕金森病 (PD) 诊断的标准. 这种工具确保了准确和标准化的诊断,改善了患者护理和临床试验.
科学领域:
- 神经学 神经学
- 医疗信息学 医疗信息学
背景情况:
- 帕金森病 (PD) 诊断依赖于复杂的标准,具有挑战性的手动应用和电子健康记录集成.
- 现有的PD诊断标准缺乏标准化的电子支持,阻碍了一致的临床应用.
- 需要一个临床决策支持 (CDS) 系统来促进准确的PD诊断.
研究的目的:
- 为帕金森病 (PD) 开发和评估临床决策支持 (CDS) 平台.
- 为了使运动障碍学会对帕金森病 (MDS-PD) 的临床诊断标准能够系统和准确地应用.
主要方法:
- 开发一个模块化和可扩展的信息平台 (CDS-PD) 来记录患者信息.
- 在CDS-PD平台内基于MDS-PD标准的诊断算法的实时应用.
- 评估CDS-PD平台与手动应用MDS-PD标准的一致性.
主要成果:
- CDS-PD平台与经验丰富的神经病学家的MDS-PD标准的应用有很高的一致性.
- 该平台促进了PD诊断标准的系统和准确实施.
结论:
- CDS-PD平台代表了标准化电子实施MDS-PD标准的重大进步.
- 该工具支持准确的PD患者护理,并增强临床试验过程在 point-of-care.
- CDS-PD平台可供临床医生和研究人员使用.
相关概念视频
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
Nursing Clinical Information System
865
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
865
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
35
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35


